First Report of an SH2D1A Mutation Associated with X-Linked Lymphoproliferative Disease in Turkey
Selman Kesici,
Ebru Yılmaz Keskin,
Samuel C.c. Chiang,
Çiğdem Seher Kasapkara,
Takuya Sekine,
Meltem Akçaboy,
Ali Fettah,
Yenan T. Bryceson
Affiliations
Selman Kesici
Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Clinic of Pediatric Intensive Care, Ankara, Turkey
Ebru Yılmaz Keskin
Süleyman Demirel University Faculty of Medicine, Department of Pediatric Hematology and Oncology, Isparta, Turkey
Samuel C.c. Chiang
Karolinska University Hospital Huddinge, Karolinska Institute, Center for Hematology and Regenerative Medicine, Department of Medicine, Stockholm, Sweden
Çiğdem Seher Kasapkara
Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Clinic of Pediatric Metabolism and Nutrition, Ankara, Turkey
Takuya Sekine
Karolinska University Hospital Huddinge, Karolinska Institute, Center for Hematology and Regenerative Medicine, Department of Medicine, Stockholm, Sweden
Meltem Akçaboy
Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Clinic of Pediatrics, Ankara, Turkey
Ali Fettah
Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Clinic of Pediatric Hematology and Oncology, Ankara, Turkey
Yenan T. Bryceson
Karolinska University Hospital Huddinge, Karolinska Institute, Center for Hematology and Regenerative Medicine, Department of Medicine, Stockholm, Sweden
